Stockreport

Prana Receives First Orphan Drug Designation from the FDA for the Treatment of Multiple System Atrophy

PRANA BIOTECH  (PRAN) 
US:NASDAQ Investor Relations: pranabio.com/investors
PDF MELBOURNE, Australia & SAN FRANCISCO--(BUSINESS WIRE)-- Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company”) has today announced the [Read more]